Akoya Biosciences, Inc. (AKYA) Financials
Stock symbol AKYA is outdated, potentially delisted? Maybe it is available on other exchange?
AKYA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 112.6 million | 118.5 million |
| Dec. 31, 2024 | 125.0 million | 117.4 million |
| Sept. 30, 2024 | 130.0 million | 116.3 million |
| June 30, 2024 | 143.7 million | 121.5 million |
AKYA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -7.4 million | 2.2 million |
| Dec. 31, 2024 | -4.0 million | 2.1 million |
| Sept. 30, 2024 | -9.7 million | 1.9 million |
| June 30, 2024 | -11.2 million | 2.7 million |
AKYA Net Income
No data available :(
AKYA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 27.5 million | 4.0 million | 7.2 million |
| Dec. 31, 2024 | 35.0 million | 80.9 million | 4.7 million |
| Sept. 30, 2024 | 35.9 million | 81.2 million | 9.0 million |
| June 30, 2024 | 45.2 million | 81.4 million | 9.0 million |
AKYA Shares Outstanding
AKYA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | 204000 | 5.6 million | 17.6 million | - |
| Dec. 31, 2024 | 1.0 million | 4.4 million | 15.7 million | - |
| Sept. 30, 2024 | 434000 | 4.5 million | 14.7 million | - |
| June 30, 2024 | 170000 | 5.3 million | 19.1 million | - |
AKYA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | 16.6 million | 6.8 million |
| Dec. 31, 2024 | 21.3 million | 7.0 million |
| Sept. 30, 2024 | 18.8 million | 7.1 million |
| June 30, 2024 | 23.2 million | 9.8 million |
AKYA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AKYA
Price: $1.29
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.96 USD
P/E Ratio: -1.42
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 51598
Market Capitalization: 67.9 million